Literature DB >> 20932934

Colorectal cancer cells - Proliferation, survival and invasion by lysophosphatidic acid.

Sei-Jung Lee1, C Chris Yun.   

Abstract

Colorectal cancer (CRC) develops through a series of genetic modifications that transforms normal colonic epithelium to an adenoma and then ultimately adenocarcinoma. A body of evidence suggests that lysophosphatidic acid (LPA) is a potent inducer of cancer progression at multiple levels. However, the pathological significance and mechanisms of LPA-mediated effects in the intestinal tract have only recently drawn interests. CRC cells have aberrant LPA receptor expression and LPA enhances proliferation, survival, and invasion of CRC cells, implying LPA and its signaling pathways as potential targets for anti-cancer therapies. The mechanisms of fostering CRC by LPA include dysregulation of transcription factors, activation of mitogen-activated protein kinases, pro-inflammatory cytokines, and angiogenic factors. This review provides a brief summary of recent advance on the effects of LPA on CRC cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932934      PMCID: PMC2975809          DOI: 10.1016/j.biocel.2010.09.021

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  34 in total

1.  Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared.

Authors:  Jonathan M Rhodes; Barry J Campbell
Journal:  Trends Mol Med       Date:  2002-01       Impact factor: 11.951

2.  LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.

Authors:  Wenlin Deng; De-An Wang; Elvira Gosmanova; Leonard R Johnson; Gabor Tigyi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-05       Impact factor: 4.052

3.  Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.

Authors:  Dai Shida; Joji Kitayama; Hironori Yamaguchi; Yurai Okaji; Nelson Hirokazu Tsuno; Toshiaki Watanabe; Yoh Takuwa; Hirokazu Nagawa
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

4.  Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.

Authors:  E J Goetzl; H Dolezalova; Y Kong; Y L Hu; R B Jaffe; K R Kalli; C A Conover
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  Top-down morphogenesis of colorectal tumors.

Authors:  I M Shih; T L Wang; G Traverso; K Romans; S R Hamilton; S Ben-Sasson; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

6.  Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins.

Authors:  Jung Woong Choi; Seyoung Lim; Yong-Seok Oh; Eung-Kyun Kim; Sun-Hee Kim; Yun-Hee Kim; Kyun Heo; Jaeyoon Kim; Jung Kuk Kim; Yong Ryul Yang; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Cell Signal       Date:  2010-03-19       Impact factor: 4.315

7.  Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission.

Authors:  Sean L Preston; Wai-Man Wong; Annie On-On Chan; Richard Poulsom; Rosemary Jeffery; Robert A Goodlad; Nikki Mandir; George Elia; Marco Novelli; Walter F Bodmer; Ian P Tomlinson; Nicholas A Wright
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

8.  NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.

Authors:  Yong-Seok Oh; Nam Won Jo; Jung Woong Choi; Hyeon Soo Kim; Sang-Won Seo; Kyung-Ok Kang; Jong-Ik Hwang; Kyun Heo; Sun-Hee Kim; Yun-Hee Kim; In-Hoo Kim; Jae Ho Kim; Yoshiko Banno; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 9.  Signaling pathways in intestinal development and cancer.

Authors:  Elena Sancho; Eduard Batlle; Hans Clevers
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

10.  Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.

Authors:  Dai Shida; Toshiaki Watanabe; Junken Aoki; Kotaro Hama; Joji Kitayama; Hirofumi Sonoda; Yasuhiro Kishi; Hironori Yamaguchi; Shin Sasaki; Akihiro Sako; Tsuyoshi Konishi; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

View more
  15 in total

1.  Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.

Authors:  Yi Xiao; F Peter Guengerich
Journal:  J Lipid Res       Date:  2012-05-16       Impact factor: 5.922

2.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.

Authors:  Ya-Lan Dong; Xue-Yun Duan; Yu-Jin Liu; Heng Fan; Meng Xu; Qian-Yun Chen; Zhen Nan; Hui Wu; Shuang-Jiao Deng
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 3.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

4.  Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.

Authors:  Ingun Heiene Tveteraas; Monica Aasrum; Ingvild Johnsen Brusevold; John Ødegård; Thoralf Christoffersen; Dagny Sandnes
Journal:  Tumour Biol       Date:  2015-09-19

5.  The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.

Authors:  Jacob A Gardner; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

Review 6.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

7.  Release of cyclic phosphatidic acid from gelatin-based hydrogels inhibit colon cancer cell growth and migration.

Authors:  Tamotsu Tsukahara; Kimiko Murakami-Murofushi
Journal:  Sci Rep       Date:  2012-09-24       Impact factor: 4.379

8.  LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.

Authors:  Fernanda Leve; Rubem J Peres-Moreira; Renata Binato; Eliana Abdelhay; José A Morgado-Díaz
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

9.  Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.

Authors:  Valentina Zuckerman; Eugene Sokolov; Jacob H Swet; William A Ahrens; Victor Showlater; David A Iannitti; Iain H Mckillop
Journal:  Oncotarget       Date:  2016-01-19

10.  Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI).

Authors:  Christine Tara Peterson; Joseph Lucas; Lisa St John-Williams; J Will Thompson; M Arthur Moseley; Sheila Patel; Scott N Peterson; Valencia Porter; Eric E Schadt; Paul J Mills; Rudolph E Tanzi; P Murali Doraiswamy; Deepak Chopra
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.